Clinomics Inc.

KOSDAQ:A352770 Voorraadrapport

Marktkapitalisatie: ₩24.1b

Clinomics Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

ByungChul Kim

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.01%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Benign Growth For Clinomics Inc. (KOSDAQ:352770) Underpins Stock's 33% Plummet

Mar 15
Benign Growth For Clinomics Inc. (KOSDAQ:352770) Underpins Stock's 33% Plummet

CEO

ByungChul Kim (59 yo)

no data

Tenure

Mr. ByungChul Kim serves as Chief Executive Officer of Clinomics Inc. He is Genetics Expert. He has been ommercialized Asia’s first personalized genome analysis product (Theragen Etex HelloGene); Developed...